Renal Cancer - Results from #5860

PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis March 2, 2016

Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis March 2, 2016

Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy March 1, 2016

A technetium 99m-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo March 1, 2016

Comparison of Postoperative Morphine Requirements in Renal Donors and Patients With Renal Carcinoma Undergoing Laparoscopic Nephrectomy February 29, 2016

Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma February 29, 2016

Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review February 24, 2016

Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma February 24, 2016

Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma February 22, 2016

Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus February 22, 2016

Solitary renal metastasis of esophageal squamous cell carcinoma mimicking primary renal neoplasm - A case report and literature review February 19, 2016

Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma February 19, 2016

Metabolic vulnerabilities of MYC-induced cancer February 19, 2016

Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer February 19, 2016

MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma February 19, 2016

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship February 18, 2016

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma February 18, 2016

Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy February 18, 2016

Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients February 18, 2016

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib February 18, 2016

Page 294 of 458